When reports of rare but severe blood clots emerged after Johnson & Johnson’s COVID vaccine, they threatened to overshadow an otherwise successful immunization campaign and left scientists searching ...

Get a closer look at the biotech ophthalmology landscape to discover exactly how companies are approaching the treatment of eye diseases.

Researchers have identified the molecular mechanism behind vaccine-induced immune thrombotic thrombocytopenia, or VITT, a ...

With a clutch of key data and planned regulatory applications this year from Avidity Biosciences, REGENXBIO and Capricor ...

The biopharmaceutical sector is transitioning from reactive off-line quality control to a proactive quality by design (QbD) framework. Process analytical technology (PAT) enables this shift through ...

The tiny shell protecting the HIV virus resembles a slightly rounded ice cream cone, but there is nothing sweet about it.

Age, biological sex, and human genetic factors influence the production of antibodies during the immune response. A team of scientists from the Institut Pasteur, the CNRS and the Collège de France ...

Liver cancer is one of the three deadliest cancers worldwide, and metabolic dysfunction-related cases have become ...

"Successful automation depends on orchestration, not just robotics," notes Werner Maas, PhD, CEO, Hudson Lab Automation.

HIV-1 can be neutralized by antibodies which bind to vulnerable structures on the virus surface. One such vulnerable site is ...